Abstract
Vertebrobasilar insufficiency is best understood as a clinical syndrome of transient or persistent ischemia in the posterior circulation rather than as a final etiologic diagnosis. This narrative review thesis summarizes a practical evidence-based approach to its recognition, diagnostic confirmation, acute treatment, and prevention. A targeted search of PubMed/MEDLINE and professional-society repositories was performed for English-language guidelines, randomized trials, systematic reviews, meta-analyses, and diagnostic studies published from 1 January 2021 through 13 August 2026. The synthesis shows that dizziness or vertigo alone has low specificity, whereas acute imbalance with central ocular-motor signs, diplopia, dysarthria, dysphagia, limb or truncal ataxia, crossed deficits, visual-field loss, or altered consciousness should trigger an urgent posterior-circulation stroke pathway. Non-contrast computed tomography excludes hemorrhage but is insensitive for small posterior fossa infarction; computed-tomography angiography or magnetic-resonance angiography identifies arterial occlusion, stenosis, or dissection, and diffusion-weighted magnetic resonance imaging defines tissue injury. Early negative diffusion-weighted imaging does not fully exclude ischemia. Treatment is time- and mechanism-dependent: eligible patients require reperfusion assessment, selected basilar-artery occlusion warrants thrombectomy evaluation, and antithrombotic therapy must be matched to non-cardioembolic, cardioembolic, or dissection mechanisms. Long-term prevention integrates blood-pressure and lipid control, smoking cessation, physical activity, diabetes management, rhythm surveillance, and adherence support. Routine intracranial or vertebral stenting is not a first-line preventive strategy. A syndrome-tissue-vessel-mechanism framework reduces diagnostic anchoring and links findings to actionable treatment.